Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
42.17
-3.34 (-7.33%)
Mar 13, 2025, 4:00 PM EDT - Market closed
Tempus AI Revenue
In the year 2024, Tempus AI had annual revenue of $693.40M with 30.38% growth. Tempus AI had revenue of $200.68M in the quarter ending December 31, 2024, with 35.85% growth.
Revenue (ttm)
$693.40M
Revenue Growth
+30.38%
P/S Ratio
7.86
Revenue / Employee
$288,916
Employees
2,400
Market Cap
7.26B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
TEM News
- 2 days ago - Tempus Announces Acquisition of Deep 6 AI - Business Wire
- 15 days ago - Tempus AI: Buying The Dip After 2025 Guidance Raise - Seeking Alpha
- 16 days ago - Tempus AI Earnings: A Promising Business, But There Are Risks - Seeking Alpha
- 16 days ago - Tempus AI, Inc. (TEM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Tempus Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 17 days ago - Tempus AI Gears Up For Q4 Earnings After 101% YTD Surge - Benzinga
- 20 days ago - 3 Biotech/Healthcare Names Under $10 I Am Buying Now - Seeking Alpha
- 22 days ago - Tempus to Present at TD Cowen's 45th Annual Health Care Conference - Business Wire